TAVI in intermediate-risk patients - What should we be doing now?
Chairperson: M. Haude
Co-chairperson: N. Moat
Evaluator: H. Moellmann
Control Desk: M. Khawaja
Consult this session video from EuroPCR 2015 on TAVI in intermediate-risk patients: what should we be doing now?
- To learn how to define intermediate-risk in TAVI patients
- To review the available evidence
- To understand the current limitations of TAVI in this patient group